Johnson & Johnson single-dose COVID-19 vaccine protects against virus
WPVI
Share:
PHILADELPHIA (WPVI) Studies show the Johnson & Johnson vaccine is safe and 86% effective in preventing severe complications from COVID-19.
On Friday, an FDA advisory committee will review those findings and decide if it will grant emergency use authorization.
The one-dose Johnson & Johnson vaccine could arrive in the Philadelphia area by the beginning of March, officials said.
Two million doses are ready to ship nationwide next week pending FDA emergency use approval, and 20 million doses could be nationally available by the end of March. It could potentially change the game in how fast we could accelerate the vaccination program, said David Mihalic, the director of pharmacy services for Einstein Healthcare Network.